JAGX News

Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return. For the second week in a row, the general partner of a midstream natural gas pipelines MLP priced an upsized IPO above its range to become the year's largest company to go public by market cap. We also saw the ...read more

Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, raised $20 million by offering 2.86 million shares at $7, the low end of its originally proposed $7 to $9 range. Jaguar Animal Health listed on the NASDAQ under the symbol JAGX. Aegis Capital acted as a sole bookrunner on the deal....read more

Nine IPOs are scheduled to raise $1.4 billion this week. The IPO market could see the year's largest company and the year's largest biotech by market cap begin trading in the US. Two yield plays account for two-thirds of expected proceeds. Six of the nine are development-stage health care and genetics...read more

Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, announced terms for its IPO on Friday. The San Francisco, CA-based company plans to raise $22 million by offering 3.2 million shares at a price of $7 per share. At that price, Jaguar would command a fully diluted market value of $62 million. It originally planned to...read more